World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
29495
World Ranking
17863
National Ranking
721

Overview

Michele Reni is affiliated with Vita-Salute San Raffaele University in Italy. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology with a total of 357 and 95 publications respectively.

Their work focuses on subfields including Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery, and Epidemiology. These areas reflect a multidisciplinary approach to medical science, with a dominant emphasis on cancer-related research topics.

Key topics addressed in their research include:

  • Pancreatic and Hepatic Oncology Research
  • Cancer Genomics and Diagnostics
  • Renal cell carcinoma treatment
  • Neuroendocrine Tumor Research Advances
  • PARP inhibition in cancer therapy
  • Radiomics and Machine Learning in Medical Imaging
  • Economic and Financial Impacts of Cancer

Michele Reni has published extensively in a range of scientific journals, with frequent publications in the following venues:

  • Pancreatology
  • Journal of Clinical Oncology
  • Annals of Oncology
  • Digestive and Liver Disease
  • Endoscopy

Frequent co-authors who collaborate with Michele Reni include Massimo Falconi, Gabriele Capurso, Paolo Giorgio Arcidiacono, Marina Macchini, and Giulia Orsi, highlighting a collaborative research network that supports ongoing studies.

Notable recent papers involving this researcher span key clinical trials and studies in oncology, demonstrating contributions to the field's evolving knowledge base. Examples include:

  • Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer, 2022, Journal of Clinical Oncology
  • Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial, 2022, Journal of Clinical Oncology
  • Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study, 2021, Annals of Oncology
  • Overall survival from the phase 3 POLO trial: Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer., 2021, Journal of Clinical Oncology
  • Geographic and Ethnic Heterogeneity of Germline BRCA1 or BRCA2 Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial, 2020, Journal of Clinical Oncology

Best Publications

  • Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

    Daniel D. Von Hoff;Thomas Ervin;Francis P. Arena;E. Gabriela Chiorean

  • Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer

    Talia Golan;Pascal Hammel;Michele Reni;Eric Van Cutsem

  • Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience

    Andrés J M Ferreri;Jean Yves Blay;Michele Reni;Felice Pasini

  • Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer

    Lucia De Monte;Michele Reni;Elena Tassi;Daniela Clavenna

  • High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

    Andrés J. M. Ferreri;Michele Reni;Marco Foppoli;Maurizio Martelli

  • Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized Trial

    René Olivier Mirimanoff;Thierry Gorlia;Warren Mason;Martin J. Van Den Bent

  • Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.

    Andrés J M Ferreri;Kate Cwynarski;Elisa Pulczynski;Maurilio Ponzoni

  • Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

    Brigitta G Baumert;Brigitta G Baumert;Monika E Hegi;Martin J van den Bent;Andreas von Deimling

  • A multicenter study of treatment of primary CNS lymphoma

    A. J.M. Ferreri;M. Reni;F. Pasini;A. Calderoni

  • INTRA- AND INTER-OBSERVER VARIABILITY IN CONTOURING PROSTATE AND SEMINAL VESICLES : IMPLICATIONS FOR CONFORMAL TREATMENT PLANNING

    Claudio Fiorino;Michele Reni;Angelo Bolognesi;Giovanni Mauro Cattaneo

  • Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

    Andres J. M. Ferreri;Kate Cwynarski;Elisa Pulczynski;Christopher P. Fox

  • Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial.

    Michele Reni;Stefano Cordio;Carlo Milandri;Paolo Passoni

  • Correlations Between O6-Methylguanine DNA Methyltransferase Promoter Methylation Status, 1p and 19q Deletions, and Response to Temozolomide in Anaplastic and Recurrent Oligodendroglioma: A Prospective GICNO Study

    Alba A. Brandes;Alicia Tosoni;Giovanna Cavallo;Michele Reni

  • Glioblastoma in adults

    Alba A. Brandes;Alicia Tosoni;Enrico Franceschi;Michele Reni

  • Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2-3 trial.

    Michele Reni;Gianpaolo Balzano;Silvia Zanon;Alessandro Zerbi

  • Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: Results of a critical review of the literature

    M. Reni;A. J. M. Ferreri;M. P. Garancini;E. Villa

  • Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis.

    Giovanni Luca Ceresoli;Michele Reni;Giuseppe Chiesa;Angelo Carretta

  • The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma

    Federica Marchesi;Lorenzo Piemonti;Giuseppe Fedele;Annarita Destro

  • Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer

    Paolo Giorgio Arcidiacono;Silvia Carrara;Michele Reni;Maria Chiara Petrone

  • Temozolomide as salvage treatment in primary brain lymphomas

    M Reni;F Zaja;W Mason;J Perry

Frequent Co-Authors

Massimo Falconi
Massimo Falconi Vita-Salute San Raffaele University
Andrés J.M. Ferreri
Andrés J.M. Ferreri Vita-Salute San Raffaele University
Claudio Doglioni
Claudio Doglioni Vita-Salute San Raffaele University
Alba A. Brandes
Alba A. Brandes Institute of Neurological Sciences
Eileen M. O’Reilly
Eileen M. O’Reilly Memorial Sloan Kettering Cancer Center
David Goldstein
David Goldstein University of New South Wales
Giampaolo Tortora
Giampaolo Tortora University of Verona
Michele Milella
Michele Milella University of Verona
Stefano Cascinu
Stefano Cascinu Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens doors to a range of healthcare career options, many of which can be pursued online. For those with non-nursing backgrounds interested in advanced practice, direct entry msn programs for non-nursing majors online offer a fast track to becoming a nurse practitioner or clinical leader without a traditional nursing degree.

If you’re seeking a more accessible route, consider exploring the easiest nursing schools to get into, which can help ease your entry into this high-demand field. For students interested in administrative healthcare roles, accredited medical billing and coding schools online provide flexible training, often with financial aid options.

Some nursing pathways may require entrance exams, but there are programs where you may not need to take the TEAS or HESI. Wondering, do you have to take a teas test for lpn? It depends on the school, but many now offer alternatives or omit this requirement to help more candidates enter the profession.

Best Scientists Citing Michele Reni

Trending Scientists

Recently Published Articles